- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: her2 positive breast cancer
Total 95278 results
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHER2-positive Recurrent / Metastatic Breast CancerChina
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerUnited States
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterIncyte CorporationWithdrawnBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HER2-positive Breast Cancer
-
GE HealthcareLaboratory Corporation of AmericaNot yet recruiting
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedHER2-positive Breast CancerChina
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States
-
Iambic Therapeutics, IncRecruiting
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
UNICANCERActive, not recruiting
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
M.D. Anderson Cancer CenterZymeworks BC Inc.Active, not recruitingBreast Cancer | HER2-positiveUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
Rawalpindi Medical CollegeCompleted
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
Washington University School of MedicineWithdrawn
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterPuma Biotechnology, Inc.Active, not recruitingBreast CancerUnited States
-
Helsinki University Central HospitalActive, not recruiting
-
Fudan UniversityUnknown
-
Celularity IncorporatedActive, not recruitingMetastatic HER2 Positive Gastroesophageal Junction CancerUnited States
-
Tomsk National Research Medical Center of the Russian...Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of SciencesCompletedPrimary Breast CancerRussian Federation
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals CorporationCompletedMetastatic Breast CancerKorea, Republic of
-
Ottawa Hospital Research InstituteCompleted
-
Fudan UniversityHoffmann-La RocheUnknown
-
Heidelberg Pharma AGU.S. Army Medical Research and Development CommandCompletedMetastatic Breast CancerUnited States, Belgium, Brazil, Germany, Israel
-
Henan Cancer HospitalRecruitingHER2 Low Breast CarcinomaChina
-
Chinese PLA General HospitalFudan UniversityRecruitingHER2 Positive Advanced Solid TumorsChina
-
Shengjing HospitalRecruiting
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Hangzhou Adcoris Biopharmacy Co., LtdEnrolling by invitationHER2-positive Advanced Solid TumorChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Samsung Medical CenterRecruitingBreast CancerKorea, Republic of
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingHER2 Positive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | HER2-positive Breast Cancer | Advanced Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Lucia Del Mastro,MDCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
Prof. W. JanniActive, not recruitingHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany